Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.67USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$0.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
230,413
52-wk High
$1.80
52-wk Low
$0.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Feb-18 2 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.05 0.10 0.00 --
Year Ending Feb-18 2 0.00 0.00 0.00 --
Year Ending Mar-19 3 0.10 0.29 0.00 --
Year Ending Mar-20 2 0.64 1.28 0.00 --
Earnings (per share)
Quarter Ending Feb-18 1 -0.20 -0.20 -0.20 --
Quarter Ending Mar-19 2 -0.11 -0.05 -0.17 --
Year Ending Feb-18 2 -0.64 -0.29 -0.98 --
Year Ending Mar-19 3 -0.49 -0.21 -0.73 --
Year Ending Mar-20 2 -0.28 -0.17 -0.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 34.39
P/E High - Last 5 Yrs. -- 40.59 46.24
P/E Low - Last 5 Yrs. -- 23.99 24.59
Beta -- 0.91 0.91
Price to Sales (TTM) -- 4.00 6.22
Price to Book (MRQ) -- 5.02 5.20
Price to Tangible Book (MRQ) -- 5.76 6.74
Price to Cash Flow (TTM) -- 23.20 24.17
% Owned Institutions -- 0.95 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.21 4.94
Payout Ratio(TTM) -- 45.68 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.33 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 4.80 6.50
Sales - 5 Yr. Growth Rate -- 10.00 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 17.26 23.09
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.49
Capital Spending - 5 Yr. Growth Rate -- 15.23 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.28
Current Ratio (MRQ) -- 3.02 3.10
LT Debt to Equity (MRQ) -- 8.89 11.49
Total Debt to Equity (MRQ) -- 12.69 16.03
Interest Coverage (TTM) -- 35.18 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.41 54.44
Gross Margin - 5 Yr. Avg. -- 51.86 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.41 13.16
Operating Margin (TTM) -- 14.42 6.07
Operating Margin - 5 Yr. Avg. -- 14.55 8.47
Pre-Tax Margin (TTM) -- 14.96 7.02
Pre-Tax Margin - 5 Yr. Avg. -- 14.97 8.71
Net Profit Margin (TTM) -- 11.16 3.12
Net Profit Margin - 5 Yr. Avg. -- 11.23 4.91
Effective Tax Rate (TTM) -- 23.45 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.65 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 997,011,333 873,051,409
Net Income/Employee (TTM) -- 118,232,370 103,483,755
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.56
Asset Turnover (TTM) -- 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.98 11.45
Return on Assets - 5 Yr. Avg. -- 13.28 12.50
Return on Investment (TTM) -- 15.55 14.96
Return on Investment - 5 Yr. Avg. -- 17.28 16.23
Return on Equity (TTM) -- 16.92 16.52
Return on Equity - 5 Yr. Avg. -- 18.21 17.37
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.